Mana.bio

👥 24 employees💰 Last funded Oct 2021
Biotechnology Research
LinkedIn
Mana.bio is an AI based drug delivery startup, creating a platform for Lipid Nanoparticle (LNP) development for oligonucleotide therapies including mRNA-based therapeutics, vaccines and gene therapy.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Mana.bio?
Mana.bio has 1 investors on record on gritt.io.
When did Mana.bio last raise funding?
The most recent investment in Mana.bio recorded on gritt.io was in October 2021.
What industry is Mana.bio in?
Mana.bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.